Founded
Address
Polaris Venture Partners Inc
1000 Winter Street
Suite 3350
Waltham, MA 02451
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 31159
Corporate information
Official name
Polaris Venture Partners Incorporated
Registration country
Company type
Multistage venture capital investors with focus Technology, Healthcare and ConsumerFunding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 166Company | Profile | Country | Date Sort ascending | Funding | ||
---|---|---|---|---|---|---|
Jibe Inc | Software company that provides enterprises with consumer recruiting solutions. | Seed Initial investment | ||||
Formspring.me Inc | Series A | |||||
ShoeDazzle Inc | Leading membership retailer offering personalized styles in women's shoes and accessories. | Series A | ||||
Sun Catalytix Corp | Energy storage and renewable fuels technology company. | N/A | ||||
Fate Therapeutics Inc | Series B Follow-on investment | |||||
Adimab LLC | Developer of a human antibody discovery platform in yeast. | Series D | ||||
Cerulean Pharma Inc | Series B | |||||
Egnyte Inc | Series A | |||||
Ocular Therapeutix Inc | A medical device company that is currently engaged in the development of in situ formed hydrogel therapeutic products specifically for ophthalmology. | Series C Initial investment | ||||
Pulmatrix Inc | Discovering a new class of host-targeted therapies that pathogen independently treat | Series A | ||||
Selecta Biosciences Inc | A biotechnology company developing a new class of synthetic nanoparticle vaccines. | Series B | ||||
Infinite Power Solutions Inc | Infinite Power Solutions, Inc. (IPS) develops, manufactures, and markets ultra-thin, flexible, rechargeable lithium micro-batteries. | Series B | ||||
Cardiac Concepts Inc | Now known as Respicardia Inc | Series B | ||||
LOLapps | Developer of Facebook applications and games | Series A | ||||
Living Proof Inc | Series A | |||||
Follica Inc | Developer of a novel therapies for conditions and disorders of the hair follicle, the epicenter for the development and replenishment of human hair. | Series B | ||||
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series D | ||||
Wakonda Technologies Inc | Series A | |||||
Thing Labs Inc | Series A | |||||
Sprout (Chipin Inc) | Series B | |||||
Trevena Inc | Series A | |||||
Archus Orthopedics Inc | Spinal and orthopedic implant and instrument company. | Series C | ||||
Ice.com | Web-based jewelry retailer. | Series A | ||||
Quantcast Corp | Internet audience reporting and analysis services. | Series B | ||||
Bind Biosciences Inc | Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue | Series B |